Skip to main content
LUCY
NASDAQ Industrial Applications And Services

Shareholders Approve 1-for-2 to 1-for-12 Reverse Split at Annual Meeting

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.752
Mkt Cap
$6.726M
52W Low
$0.65
52W High
$2
52W Position info
16% above low
Off High info
62% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

LUCY sits 16% above its 52-week low of $0.65 on light trading volume (0.1× avg).

Summary

Innovative Eyewear shareholders approved a reverse stock split of between 1-for-2 and 1-for-12, re-elected all four directors and ratified Cherry Bekaert as auditor. The board now has authority to set the ratio and timing to address the Nasdaq bid-price deficiency.


Key Events · Corporate Governance and Compliance · LUCY

  • Reverse Split Approved by Shareholders

    Stockholders approved the Reverse Stock Split Amendment at a ratio of between 1-for-2 and 1-for-12, with 3,338,572 votes for, 1,700,215 against and 41,191 abstaining.

  • Board Retains Ratio and Timing Discretion

    The filing does not state the exact split ratio or effective date; the board may implement any ratio within the approved 1-for-2 to 1-for-12 range.

  • Nasdaq Bid-Price Cure Tool

    The authorization follows the October 15, 2026 8-K disclosing a Nasdaq minimum bid price deficiency notice received October 9, with a cure deadline of April 7, 2027.

  • Directors Re-Elected, Auditor Ratified

    Harrison Gross, Kristen McLaughlin, Louis Castro and Olivia Bartlett were elected; Cherry Bekaert LLP was ratified as independent auditor for fiscal 2026 with 4,524,861 votes for and 507,164 against.


Analysis · LUCY · Industrial Applications And Services

Management now has authorization for a reverse split, a tool to cure the Nasdaq minimum bid price deficiency disclosed on October 15 (deadline April 7, 2027). The vote was not unanimous: roughly 1.70M shares voted against versus 3.34M for. Because the board retains discretion over the exact ratio and timing, the actual split date and ratio remain unannounced. With the ATM exhausted and cash down to $3.2M as of the last 10-Q, the split is primarily a listing-survival step rather than a change to the underlying business.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LUCY was trading at $0.75 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.7M. The 52-week trading range was $0.65 to $2.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LUCY - Latest Insights

LUCY
Nov 09, 2026, 1:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.8329
Real-time Price: $0.752 info
Change: -$0.0809 (-10%) info
Market Cap: $6.726M info
LUCY
Nov 09, 2026, 11:45 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.8491
Real-time Price: $0.752 info
Change: -$0.0971 (-11%) info
Market Cap: $6.726M info
LUCY
Oct 15, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.8425
Real-time Price: $0.752 info
Change: -$0.0905 (-11%) info
Market Cap: $6.726M info
LUCY
Oct 06, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.9445
Real-time Price: $0.752 info
Change: -$0.1925 (-20%) info
Market Cap: $6.726M info
LUCY
Oct 05, 2026, 9:50 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.9124
Real-time Price: $0.752 info
Change: -$0.1604 (-18%) info
Market Cap: $6.726M info